XML 15 R2.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2018
Dec. 31, 2017
Current Assets:    
Cash $ 2,832,429 $ 5,954,017
Prepaid expenses 135,591 108,075
Total Current Assets 2,968,020 6,062,092
Property and equipment, net 32,434 56,595
In-process research and development 3,190,000 3,190,000
Goodwill 1,870,924 1,870,924
Other assets 127,794 73,289
Total Assets 8,189,172 11,252,900
Current Liabilities:    
Accounts payable 748,428 1,556,883
Accrued expenses 661,421 1,046,698
Convertible debt 1,440,000  
Total Current Liabilities 2,849,849 2,603,581
Contingent consideration 2,590,000 3,380,000
Deferred tax liability 360,700 896,700
Deferred rent liability 9,235  
Derivative financial instruments, at estimated fair value-warrants 404,337 669,462
Total Liabilities 6,214,121 7,549,743
Commitments and contingencies (Note 13)
Stockholders' Equity:    
Convertible preferred stock
Common stock-$0.0001 par value per share; 120,000,000 shares authorized, 16,608,512 and 9,792,497 shares issued and outstanding at December 31, 2018 and December 31, 2017, respectively 1,661 979
Additional paid in capital 76,651,203 69,676,687
Accumulated deficit (76,463,932) (67,014,637)
Total Stockholders' Equity 1,975,051 3,703,157
Total Liabilities and Stockholders' Equity 8,189,172 11,252,900
Series A convertible preferred stock    
Stockholders' Equity:    
Convertible preferred stock 855,808 $ 1,040,128
Series C convertible preferred stock    
Stockholders' Equity:    
Convertible preferred stock $ 930,311